comparemela.com
Home
Live Updates
Actuate Therapeutics Announces Primary Endpoint Met In Phase 2 Study In Pancreatic Cancer : comparemela.com
Actuate Therapeutics Announces Primary Endpoint Met In Phase 2 Study In Pancreatic Cancer
CHICAGO, IL and FORT WORTH, TX (PRWEB) October 28, 2021 -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, today announced
Related Keywords
Chicago ,
Illinois ,
United States ,
Northwestern University ,
Anwaar Saeed ,
Devalingam Mahalingam ,
Benedito Carneiro ,
Daniel Schmitt ,
Actuate Therapeutics Inc ,
University Of Kansas Cancer Center ,
Brown University ,
Kansas Cancer ,
Fast Track Status ,
Actuate Therapeutics ,
Press Release ,
comparemela.com © 2020. All Rights Reserved.